It was reported instead that Sema3A mRNA and protein expression is lower in ovarian carcinoma compared to normal tissue, and tumors with lowest levels are significantly associated with higher FIGO stage, histological grade, and the presence of lymphatic and distant metastasis 53. Here, SEMA3A is linked to ovarian carcinoma.